RTTNews | Dec 1, 2021 07:38AM EST

07:38 Wednesday, December 1, 2021 (RTTNews.com) - SAB Biotherapeutics Announces SAB-176 Meets Primary Endpoint In Phase 2a Challenge Study

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2021 RTTNews.com All Rights Reserved